| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0016-5085(90)90635-E |
| P698 | PubMed publication ID | 2394334 |
| P2093 | author name string | S W Schalm | |
| H A Pols | |||
| J C Birkenhäger | |||
| P P Kooij | |||
| F N Van Berkum | |||
| R Beukers | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 1134-1139 | |
| P577 | publication date | 1990-10-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids | |
| P478 | volume | 99 |
| Q71068540 | Amount and composition of bone minerals in chronic liver disease |
| Q37811999 | Bone Disorders in Chronic Liver Diseases |
| Q34410041 | Bone disease after liver transplantation |
| Q34787714 | Bone involvement in patients with chronic cholestasis |
| Q44003868 | Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease |
| Q79988065 | Bone mineral density among cirrhotic patients awaiting liver transplantation |
| Q37182934 | Clinical features and management of primary biliary cirrhosis. |
| Q73130933 | Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study |
| Q28069053 | Diagnosis and Management of Cirrhosis-Related Osteoporosis |
| Q74232019 | Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis |
| Q24244255 | Glucocorticosteroids for primary biliary cirrhosis |
| Q24685899 | Guidelines on the management of osteoporosis associated with chronic liver disease |
| Q27004571 | Hepatic osteodystrophy |
| Q35635642 | Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. |
| Q36767051 | Immunosupressive therapy for primary biliary cirrhosis |
| Q50711662 | Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well-preserved liver function. |
| Q44513824 | Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease |
| Q35573921 | Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis |
| Q44593072 | The heterogeneity of bone disease in cirrhosis: a multivariate analysis |
| Q77619532 | Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study |
Search more.